ADAM10 and neoplasm: In proof-of-concept preclinical experiments, blocking ADAM10 cleavage suppresses tumor growth (both volume and proliferation36) This finding is consistent with other preclinical studies in which a related inhibitor, INCB7839, reduced tumor growth malignant glioma growth and mouse mortality.37